MORGAN STANLEY - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 217 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$61,206,234
-11.2%
1,608,996
+112.6%
0.01%
-14.3%
Q2 2023$68,932,217
+38.8%
756,665
+0.5%
0.01%
+40.0%
Q1 2023$49,658,778
+220.2%
752,862
+151.1%
0.01%
+150.0%
Q4 2022$15,506,948
+1.7%
299,883
+34.3%
0.00%0.0%
Q3 2022$15,250,000
-25.6%
223,276
-50.7%
0.00%
-33.3%
Q2 2022$20,485,000
+59.1%
453,020
+78.8%
0.00%
+50.0%
Q1 2022$12,875,000
+302.5%
253,389
+274.5%
0.00%
Q4 2021$3,199,000
-45.3%
67,659
-61.8%
0.00%
-100.0%
Q3 2021$5,843,000
-59.7%
177,296
-22.7%
0.00%
-50.0%
Q2 2021$14,494,000
+122.2%
229,341
+50.9%
0.00%
+100.0%
Q1 2021$6,523,000
+13.7%
152,024
+51.5%
0.00%0.0%
Q4 2020$5,739,000
+377.9%
100,345
+152.1%
0.00%
Q3 2020$1,201,000
-34.8%
39,799
-29.4%
0.00%
Q2 2020$1,841,000
+38.3%
56,390
+13.6%
0.00%
Q1 2020$1,331,000
-64.5%
49,660
-59.5%
0.00%
-100.0%
Q4 2019$3,752,000
-62.2%
122,547
-70.3%
0.00%
-66.7%
Q3 2019$9,928,000
+3176.6%
412,104
+3359.3%
0.00%
Q2 2019$303,000
-98.8%
11,913
-99.0%
0.00%
-100.0%
Q1 2019$24,344,000
+3158.9%
1,248,394
+2103.1%
0.01%
Q4 2018$747,000
-30.3%
56,665
-6.0%
0.00%
Q3 2018$1,072,000
-38.8%
60,312
-24.3%
0.00%
Q2 2018$1,752,000
+286.8%
79,627
+288.4%
0.00%
Q1 2018$453,000
+10.5%
20,502
+8.4%
0.00%
Q4 2017$410,00018,9080.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders